NCT02873403

Brief Summary

Around 250 millions of people in the world (3.8%) have knee osteoarthritis (KOA). Due to aging and increasing obesity, the prevalence of KOA is expected to increase in the developed country in the next 20 years. KOA decreases quality of life of patients through chronic pain, joint stiffness, and reduced social activity, which influence emotional wellness as well. KOA has also impact on the biomechanics of the lower limbs, leading or amplifying the tibiofemoral misalignment and an increase of the medial knee joint loading. Increase of the medial knee joint loading may lead patients into a vicious circle by increasing knee pain, decreasing activities, increasing weight and disease progression. Knee brace is a non-pharmacological treatment recommended for KOA. It aims to reduce misalignment of the limb. However, the main issue is the poor compliance because of lack of effectiveness, more drawbacks than benefits, discomfort, bad fitting, migration of the brace, bulkiness, aesthetic, skin irritation, blisters and too much pressure on the knee. By its freedom in design, 3D printing may resolve most of these complaints. This study aims to compare clinical and biomechanical effectiveness, comfort and patients complaints of a knee brace made by 3D printing to a conventional knee brace. The institute for Applied Health Research of Glasgow Caledonian University (GCU) will lead the experimental trial. They will recruit men or women (40 to 70 years old) suffering from medial KOA in Glasgow area. Participants will be in study for 10 weeks. During this period, they will wear 2 different knee braces for two weeks each with a 1-week period without knee brace between. Participants will have five visits to GCU: once for leg measurement to make knee braces and four times to fill questionnaires and perform gait analysis. Besides, they will wear activity monitor for 3 non-consecutive weeks.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2016

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 19, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

March 3, 2017

Status Verified

January 1, 2017

Enrollment Period

2 months

First QC Date

July 27, 2016

Last Update Submit

March 1, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in knee pain during gait and stairs ambulation

    Measured with 10-cm visual analog scale

    Baseline and at 2 weeks

  • Change in knee adduction moment during gait and stairs ambulation

    Knee adduction moment (KAM) will be calculated from motion capture and force plate data. KAM characterizes knee loading, especially peaks and angular impulse (area under the KAM curve) to have information about maximum and total knee loading, respectively.

    Baseline and at 2 weeks

Secondary Outcomes (14)

  • Change in knee brace comfort

    Baseline and at 2 weeks

  • Change in stability feelings

    Baseline and at 2 weeks

  • Change in Symptoms

    Baseline and at 2 weeks

  • Change in quality of life

    Baseline and at 2 weeks

  • Change in physical activities: Daily distance estimate

    Second week of intervention

  • +9 more secondary outcomes

Study Arms (2)

KNEEMO knee brace & Popular knee brace

EXPERIMENTAL

Patients having medial knee osteoarthritis

Device: KNEEMO knee braceDevice: Popular knee brace

Popular knee brace &KNEEMO knee brace

EXPERIMENTAL

Patients having medial knee osteoarthritis

Device: KNEEMO knee braceDevice: Popular knee brace

Interventions

Bespoke knee brace made by additive manufacturing

KNEEMO knee brace & Popular knee bracePopular knee brace &KNEEMO knee brace

Customized knee brace used in the management of medial knee ostearthritis

KNEEMO knee brace & Popular knee bracePopular knee brace &KNEEMO knee brace

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female aged between 40 and 70 years old having radiological and symptomatic medial KOA (Kellgren-Lawrence grade II, III or IV) according to the American College of Rheumatology's clinical and radiological criteria \[83\]
  • Average knee pain \> 4/10 (VAS score assessed three times in two weeks before being included)
  • Not currently wearing knee brace
  • Varus knee alignment equal or superior to 2°
  • No or light pain from the hips, ankles, feet or lumbar spine
  • Moderately physically active
  • Able to understand written and spoken English.

You may not qualify if:

  • Mild KOA (Kellgren-Lawrence grade I)
  • Lateral or patellar KOA
  • Chronic diseases or conditions (e.g., diabetes, osteoporosis, heart disease, hypertension, neurological disorders)
  • Stroke history
  • Inflammatory arthritis (gout, RA, psoriatic arthritis, …)
  • Musculoskeletal disorders that could influence their ability to stand and walk
  • Morbid obesity (BMI \> 35)
  • Intra-articular corticosteroid/hyaluronan injection in the affected knee in the past 3 months
  • Unstable medication schedule and medication that causes dizziness
  • Severe recent modification of diet
  • Prosthetic implants in the hip, knee or ankle joint
  • Poor skin condition
  • Unable to walk, walk up and down stairs or any condition contraindicating the demands of the gait analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glasgow Caledonian University

Glasgow, United Kingdom

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Yoann Dessery, PhD

    Peacocks Medical Group

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yoann Dessery, PhD

CONTACT

Jari Pallari, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2016

First Posted

August 19, 2016

Study Start

March 1, 2017

Primary Completion

May 1, 2017

Study Completion

June 1, 2017

Last Updated

March 3, 2017

Record last verified: 2017-01

Locations